Stay updated with breaking news from Adverse Event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver
Banaras Hindu University researchers found one-third of Covaxin recipients experienced 'adverse events of special interest'. Dr. Rajiv Bahl of ICMR de
ANN ARBOR, Mich., May 20, 2024 -- Esperion and Otsuka Pharmaceutical Co., Ltd announced today that the primary endpoint was achieved in the Phase 3 trial in Japan for bempedoic acid as a...
Following four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients for Psoriasis Area and Severity Index 75 in the POETYK PSO long-term...
– Q1 Total Revenue Grew 467% Y/Y to $137.7 Million, Reflecting Strong Growth Globally – – Q1 U.S. Net Product Revenue Grew 46% Y/Y to $24.8 Million – – Q1 Retail Prescription Equivalents...